Clovis Oncology Inc EV/Sales
Was ist das EV/Sales von Clovis Oncology Inc?
EV/Sales von Clovis Oncology Inc ist 4.91
Was ist die Definition von EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Clovis Oncology Inc
Unternehmen mit ev/sales ähnlich Clovis Oncology Inc
- Elecon Engineering hat EV/Sales von 4.90
- Hamborner REIT AG hat EV/Sales von 4.90
- Dun & Bradstreet hat EV/Sales von 4.90
- Hut 8 Mining hat EV/Sales von 4.90
- Wall hat EV/Sales von 4.91
- Trainline Plc hat EV/Sales von 4.91
- Clovis Oncology Inc hat EV/Sales von 4.91
- Omkar Speciality Chemicals hat EV/Sales von 4.91
- Diversified Gas & Oil PLC hat EV/Sales von 4.91
- Tata Consultancy Services hat EV/Sales von 4.91
- Victory Securities () hat EV/Sales von 4.91
- Steris Plc hat EV/Sales von 4.91
- Diageo Plc hat EV/Sales von 4.92